To unveil the mystery of the medical and beauty industry, the bosses have stepped in one after another.
When it comes to medical beauty, it is easy to think of cosmetic surgery, hyaluronic acid, liposuction and other expensive projects, but it also illustrates the profit potential of the medical beauty industry.
According to the estimate of the China Business Industrial Research InstituteThe market will reach 136.1 billion US dollars in 2018.By 2021, the global medical beauty market will exceed 166 billion US dollars.So-young International Inc CEO Venus recently said in a public speech that医The trend that beauty has become the daily way of life of the post-00s generation has already emerged, and it will become more and more intense.
Data source: China Business Industrial Research Institute
At present, the health care department in China divides the medical and beauty industry into four types, which are:
1)Cosmetic surgeryIncluding plastic surgery and injection medicine, such as double eyelid excision, rhinoplasty, and Botox slimming injections.
2)Cosmetic dermatologyTo provide energy instrument treatment, laser hair removal, laser spot removal, radio frequency skin tightening and so on.
3)Cosmetic dentistryIncluding orthodontics (orthodontics) and cold light whitening.
4)Department of cosmetic traditional Chinese medicineFrom traditional Chinese medicine, including diet, acupuncture, massage
In the above four categories, especially the first and second categories are more popular in the market, especially the listed companies of medical and beauty are more in the first and second categories. It is worth noting that under the influence of high marketing expenses, the net profit margin of terminal service organizations is lower than its gross profit margin, and Medical App has become a new tuyere.
Look at the medical and beauty market, you can find Sequoia Capital, Jingwei, IDG and other famous investors, you can also see Baidu, Inc., Evergrande and other giants, some small and medium-sized enterprises are also not willing to lag behind.
The bosses have stepped in one after another, but you still don't know what the medical and beauty-related stocks are? Let's take a quick look at Hong Kong stocks, US stocks, A shares in which medical stocks!
Hong Kong stocks: a large number of medical and American stocks, plastic surgery, skin care are within the scope of business
Hong Kong Medical Group（2138）：The largest provider of medical beauty services in Hong KongMainly engaged in plastic surgery, microplastic surgery and doctor-operated energy instrument treatment.Its financial report for the first quarter of 2018 said that the number of active customers increased significantly during the reporting period, which contributed to a significant increase in revenue generated from the provision of medical services and health management services, and net profit increased by 39% compared with the same period last year.
Zhuoga Holdings(8358): the company provides professional skin care courses and high-quality skin care products, and its board chairman and CEO is the former famous TVB actress Li Zi.
Evergrande Health(0708): the health management division includes two parts: health care space and medical beauty and health management, and the medical and beauty business is in the promotion stage.
Haohai biotechnology(6826): plastic surgery and wound care is one of the four major product lines.
Sisram med(1696): Israeli energy source medical beauty equipment supplier giant, the first Israeli listed company of the Hong Kong Stock Exchange and the first subsidiary of Shanghai Fosun Pharmaceutical (600196.SH, 2196.HK), mainly non-invasive and minimally invasive medical beauty products.
Lifeng Holdings(1125): its own brand "Yapulide" entered Medical Beauty, and the first "Yapulide" Medical Clinic Beijing flagship store officially opened in June 2018.
* Art Star Medical Beauty (referred to as "Art Star Medical Beauty" or "Yestar"): Putian Department and the second largest private medical and beauty chain group in China submitted an application for listing on the main board to the Hong Kong Stock Exchange in June 2018, which is pending processing. According to the prospectus, the medical and beauty company recommended exclusively by China International Capital Corporation earned more than 1 billion yuan in 2017 and its net profit increased nine-fold in three years. However, in the rapid expansion, two of the three authorized agencies have been administratively penalized, and a number of lawsuits involving medical disputes have not been concluded.
Us stocks: many medical and beauty companies have their own technology and brand products
Allergan(AGN): global medical cosmetology leader, multinational company that develops, manufactures and markets medical beauty products, including botulinum toxin, breast beauty products, Frisbee intervention products and other pharmaceutical industry. In 2017, it acquired the listed company ZELTIQ Aesthetics (ZLTQ), the research, development and sale of non-invasive fat reduction (weight loss) products, using patented controlled cooling technology to selectively reduce stubborn fat eminence, unlike traditional liposuction, which does not require surgery, injection, anesthesia and other invasive means, and does not affect diet and exercise.
Establishment Labs Holdings(ESTA): a global high-tech medical equipment and beauty company dedicated to designing, developing, manufacturing and marketing innovative product portfolios consisting of advanced silicone-filled breast and body-building implants.
Evolus(EOLS): medical cosmetology company, the main market is self-paid health care. The main candidate product is the injectable preparation of 900 kDa botulinum toxin A complex.
Restoration Robotics(HAIR): hair transplant medical equipment company, has the world's only robotic hair repair system.
Sienna Biopharmaceuticals(SNNA): focus on introducing biotechnology innovations into medical dermatology and aesthetics, developing and commercializing external products for the medical dermatology and beauty markets, such as psoriasis-related inhibitors.
Cutera(CUTR): supplier of laser cosmetic equipment for treatment: pigmented lesions, skin regeneration and surface repair, tattoo removal, etc.
Sientra(SIEN): a medical cosmetology company specializing in providing products for breast augmentation and breast reconstruction, its breast augmentation technology is recognized and approved by the Food and Drug Administration in the United States.
Revance Therapeutics(RVNC): a professional pharmaceutical company in the clinical stage, focusing on the development and manufacture of new botulinum toxin type A products, including the elimination of crow's feet, eyebrow lines, etc.
AStocks: there are many cross-border enterprises, but there are no medical and beauty stocks yet.
There are mainly five related companies in A-shares, all of which are traded on the Shenzhen Stock Exchange. But it's worth noting thatThese companies do not take medical beauty as their main business, but only have a layout in the medical beauty industry. so far, no medical beauty industry company has landed on A-shares through IPO.. After Guangdong Marubeni Biotechnology Co., Ltd. was rejected in 2016, its listing application was rejected again in July 2018, first because of the specific information on the distribution model, and second, because it did not disclose that its Marumei products had been inspected and punished by the Food and Drug Administration in the third quarter.
The degree of correlation between stocks and medical cosmetology, source: cloud financial data
Lang zi shares(002612): fashion Brand Group, Medical Beauty is one of the four main businesses, including non-surgical medical beauty and surgical medical beauty.
SUNING Global(000718): Suya Medical Beauty specializes in the operation of medical and beauty industry and the integration of industry chain. As an important part of the layout of health industry, it has invested in "more beautiful" O2O platform and reached cooperation with Korean medical institutions.
Guanhao creature(300238): based on the regenerative medicine industry, provide breast tissue patches.
Qingdao Golden King(002094): the original main business is candle export and oil products trade, transforming M & An into the only all-channel, all-industry chain cosmetics operator in China.
East China medicine(000963): carry out international mergers and acquisitions in the field of medicine and beauty. In July 2018, he has made preliminary contact with the management of Sinclair Pharma, a medical and beauty listed company on the AIM stock market in London, England, and intends to invest 1 billion yuan to acquire Sinclair Pharma.
Main investment risk
Although the market size of the medical and beauty industry is large and the growth prospects are good, special attention should still be paid to--
Medical and aesthetic institutions have high customer cost, low conversion rate and unstable performance.
The strong supervision of the industry, the setting of the threshold and the daily supervision are closely watched by the competent departments of the industry, and at present, there are many chaotic phenomena in the industry, which are easily affected by regulatory policies.
Medical disputes, product safety issues and litigation risks may arise
(note: the list of medical and American stocks in this article is sorted out for Futu Information, welcome to add)
Recommended reading:China Business Industrial Research Institute: research report on the Market Prospect of China's Medical and Beauty Industry in 2018 (with full text)
Deloitte Financial Consulting: analysis of Chinese Medical Beauty Market 2017
Zhitong Finance and Economics: hyaluronic acid gross profit margin over 80%: China's 500 billion medical and beauty market is waiting to break out.
Yimei cake is favored by listed companies and the pain point of the industry gives birth to the App tuyere.
(editor / Wang Cuiling)